Associate Director, Genentech Research
To me, Decision Analysis is all about saying something that makes sense. That, in turn should guide us towards actions that also makes sense, and are aligned with our values. Although on some level, it seems that this should be obvious, I have not found it to be so in either my career or my personal life.
Leslie is an Associate Director with Genentech’s Research and Early Development Portfolio and Pipeline Planning Group. Since joining Genentech in 2014, she has split her time between working on product development strategy, cross portfolio reporting, and organizational change.
Prior to joining Genentech, she was an entrepreneur (Codornices Consulting, SageSpring Partners), a market researcher (AlphaDetail, now Quintiles), a strategy consultant (SDG) and an Engineer (Xerox, Spectra Physics).
She has a BS in Physics from Caltech and an MBA from the University of Oregon.
She has a deep commitment to community service, and currently serves on the board of the SDP (heading up the Certification Council) and the Pacific Association of Women Martial Artists (PAWMA).
When she is not in the office or on the phone, she can be found swimming, teaching kids judo or keeping bees on her roof.
Pharmaceutical drug investment decisions rely heavily on data and data analytics to inform executive-level decision-making. Recently, there is a focus on exploring new products and services in the digital arena in the hopes of unlocking value and improving decision quality. The intent of machine learning and artificial intelligence is to translate relevant data and information […]